@bashirhussain237:

🌹بادشاہ حسین ع 🙏
🌹بادشاہ حسین ع 🙏
Open In TikTok:
Region: PK
Sunday 08 November 2026 17:31:12 GMT
673
122
15
11

Music

Download

Comments

shajo58
Humanist 🌺 :
Hy Hussain jan
2026-11-08 22:11:59
0
zohaib.turi
Zohaib طورى🔰🔻🤞 :
🌺🌺🌺
2026-11-08 23:24:55
0
haider.hussain313
🚩✌️Haider Jan313❣️💔 :
😭😭😭
2026-11-08 22:32:23
0
kzm1kzm1
🇮🇹 ZEESHAN SAYED?! 🇮🇹🫀 🏹 :
😭😭😭
2026-11-08 22:08:31
0
kianan.hussain
Kianan Hussain :
🥰🥰🥰
2026-11-08 21:55:55
0
ijaz.hussain255
Ijaz Hussain :
❤️❤️❤️
2026-11-08 18:57:59
0
ijaz.hussain255
Ijaz Hussain :
🥰🥰🥰
2026-11-08 18:56:34
0
user725605879
Altaf Hussain :
😭😭😭
2026-11-08 18:51:20
0
saqlainsaqi010
꧁𝕤𝕥𝕒 𝕝𝕖𝕨𝕒𝕟𝕒𝕪 乂❤ :
😭😭😭
2026-11-08 18:47:35
0
ibrar.hussain749
ABRARHUSSAIN 261 :
🥰🥰🥰
2026-11-08 17:38:30
0
bashir.hussain.ba7
⚘@❣Its.Bashir⚘ jani❣@⚘ :
[Heartwarming][Crying]
2026-11-08 17:38:05
0
bashir.hussain.ba7
⚘@❣Its.Bashir⚘ jani❣@⚘ :
[Crying][Crying][Crying][Heartwarming]
2026-11-08 17:38:01
0
shahid.hussain7419
Shahid Hussain :
😭😭😭
2026-11-08 17:37:44
0
malangg523
😭🫶MALANG🫀😭 :
🥺🥺🥺
2026-11-08 17:33:08
0
asadali86535
🦋⍣⃝🇦saD Ali🦋 :
😭😭😭
2026-11-08 23:29:29
0
To see more videos from user @bashirhussain237, please go to the Tikwm homepage.

Other Videos

🚨 COMPOUNDED TIRZEPATIDE RECALLS — OCTOBER 2026 Two separate FDA Class II recalls involving compounded tirzepatide due to a lack of assurance of sterility. ⚠️ RECALL #1: APOTHECARY PHARMA, LLC 📍 Cary, North Carolina (503B outsourcing facility) Medication: Tirzepatide Injection Strength: 18 mg/mL Vial size: 4 mL multidose vial NDC: 85091-001-18 FDA Recall #: D-0036-2027 Recall initiated: September 24, 2026 AFFECTED LOT NUMBERS (22): AP-202622, AP-202623, AP-202624, AP-202625, AP-202627, AP-202628, AP-202629, AP-202630, AP-202631, AP-202632, AP-202633, AP-202634, AP-202635, AP-202636, AP-202637, AP-202638, AP-202639, AP-202640, AP-202641, AP-202642, AP-202643, AP-202644. Beyond-use dates: October 7–November 26, 2026. ⚠️ RECALL #2: HOUSTON RX, LLC 📍 Houston, Texas (503A compounding pharmacy) Medication: Tirzepatide/Niacinamide Injection Strength: 20 mg/2 mg per mL Vial size: 2 mL FDA Recall #: D-0040-2027 Recall initiated: September 25, 2026 AFFECTED LOT NUMBER: TZN-080326-20/2-2 Beyond-use date: December 1, 2026. 🚨 Both recalls involve a lack of assurance of sterility. These recalls do NOT involve FDA-approved Mounjaro or Zepbound. If you use compounded tirzepatide, verify the source of your medication and check your lot number. If your medication is affected, do not use it. Contact your dispensing pharmacy or prescriber for guidance. Remember: The pharmacy dispensing your medication may not be the facility that originally compounded it. #TikTokCreatorSearchInsightsIncentive #compoundglp1 #MedicationRecall
🚨 COMPOUNDED TIRZEPATIDE RECALLS — OCTOBER 2026 Two separate FDA Class II recalls involving compounded tirzepatide due to a lack of assurance of sterility. ⚠️ RECALL #1: APOTHECARY PHARMA, LLC 📍 Cary, North Carolina (503B outsourcing facility) Medication: Tirzepatide Injection Strength: 18 mg/mL Vial size: 4 mL multidose vial NDC: 85091-001-18 FDA Recall #: D-0036-2027 Recall initiated: September 24, 2026 AFFECTED LOT NUMBERS (22): AP-202622, AP-202623, AP-202624, AP-202625, AP-202627, AP-202628, AP-202629, AP-202630, AP-202631, AP-202632, AP-202633, AP-202634, AP-202635, AP-202636, AP-202637, AP-202638, AP-202639, AP-202640, AP-202641, AP-202642, AP-202643, AP-202644. Beyond-use dates: October 7–November 26, 2026. ⚠️ RECALL #2: HOUSTON RX, LLC 📍 Houston, Texas (503A compounding pharmacy) Medication: Tirzepatide/Niacinamide Injection Strength: 20 mg/2 mg per mL Vial size: 2 mL FDA Recall #: D-0040-2027 Recall initiated: September 25, 2026 AFFECTED LOT NUMBER: TZN-080326-20/2-2 Beyond-use date: December 1, 2026. 🚨 Both recalls involve a lack of assurance of sterility. These recalls do NOT involve FDA-approved Mounjaro or Zepbound. If you use compounded tirzepatide, verify the source of your medication and check your lot number. If your medication is affected, do not use it. Contact your dispensing pharmacy or prescriber for guidance. Remember: The pharmacy dispensing your medication may not be the facility that originally compounded it. #TikTokCreatorSearchInsightsIncentive #compoundglp1 #MedicationRecall

About